Literature DB >> 9295384

Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations.

H B Clark1, E N Burright, W S Yunis, S Larson, C Wilcox, B Hartman, A Matilla, H Y Zoghbi, H T Orr.   

Abstract

Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurological disorder caused by the expansion of a CAG repeat encoding a polyglutamine tract. Work presented here describes the behavioral and neuropathological course seen in mutant SCA1 transgenic mice. Behavioral tests indicate that at 5 weeks of age mutant mice have an impaired performance on the rotating rod in the absence of deficits in balance and coordination. In contrast, these mutant SCA1 mice have an increased initial exploratory behavior. Thus, expression of the mutant SCA1 allele within cerebellar Purkinje cells has divergent effects on the motor behavior of juvenile animals: a compromise of rotating rod performance and a simultaneous enhancement of initial exploratory activity. With age, these animals develop incoordination with concomitant progressive Purkinje neuron dendritic and somatic atrophy but relatively little cell loss. Therefore, the eventual development of ataxia caused by the expression of a mutant SCA1 allele is not the result of cell death per se, but the result of cellular dysfunction and morphological alterations that occur before neuronal demise.

Entities:  

Mesh:

Year:  1997        PMID: 9295384      PMCID: PMC6573461     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  25 in total

1.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy.

Authors:  A R La Spada; E M Wilson; D B Lubahn; A E Harding; K H Fischbeck
Journal:  Nature       Date:  1991-07-04       Impact factor: 49.962

2.  Purkinje cell degeneration, a new neurological mutation in the mouse.

Authors:  R J Mullen; E M Eicher; R L Sidman
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

3.  Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions.

Authors:  S Gilman; A A Sima; L Junck; K J Kluin; R A Koeppe; M E Lohman; R Little
Journal:  Ann Neurol       Date:  1996-02       Impact factor: 10.422

4.  Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.

Authors:  L Mangiarini; K Sathasivam; M Seller; B Cozens; A Harper; C Hetherington; M Lawton; Y Trottier; H Lehrach; S W Davies; G P Bates
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

5.  Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats.

Authors:  G Imbert; F Saudou; G Yvert; D Devys; Y Trottier; J M Garnier; C Weber; J L Mandel; G Cancel; N Abbas; A Dürr; O Didierjean; G Stevanin; Y Agid; A Brice
Journal:  Nat Genet       Date:  1996-11       Impact factor: 38.330

6.  Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2.

Authors:  S M Pulst; A Nechiporuk; T Nechiporuk; S Gispert; X N Chen; I Lopes-Cendes; S Pearlman; S Starkman; G Orozco-Diaz; A Lunkes; P DeJong; G A Rouleau; G Auburger; J R Korenberg; C Figueroa; S Sahba
Journal:  Nat Genet       Date:  1996-11       Impact factor: 38.330

7.  Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT.

Authors:  K Sanpei; H Takano; S Igarashi; T Sato; M Oyake; H Sasaki; A Wakisaka; K Tashiro; Y Ishida; T Ikeuchi; R Koide; M Saito; A Sato; T Tanaka; S Hanyu; Y Takiyama; M Nishizawa; N Shimizu; Y Nomura; M Segawa; K Iwabuchi; I Eguchi; H Tanaka; H Takahashi; S Tsuji
Journal:  Nat Genet       Date:  1996-11       Impact factor: 38.330

8.  SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.

Authors:  E N Burright; H B Clark; A Servadio; T Matilla; R M Feddersen; W S Yunis; L A Duvick; H Y Zoghbi; H T Orr
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

9.  Identification of a self-association region within the SCA1 gene product, ataxin-1.

Authors:  E N Burright; J D Davidson; L A Duvick; B Koshy; H Y Zoghbi; H T Orr
Journal:  Hum Mol Genet       Date:  1997-04       Impact factor: 6.150

10.  The Purkinje cell in olivopontocerebellar atrophy. A Golgi and immunocytochemical study.

Authors:  I Ferrer; D Genís; A Dávalos; L Bernadó; F Sant; T Serrano
Journal:  Neuropathol Appl Neurobiol       Date:  1994-02       Impact factor: 8.090

View more
  107 in total

Review 1.  Neurologic disorders of gait.

Authors:  L Sudarsky
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

2.  Suppression of calbindin-D28k expression exacerbates SCA1 phenotype in a disease mouse model.

Authors:  Parminder J S Vig; Jinrong Wei; Qingmei Shao; Maripar E Lopez; Rebecca Halperin; Jill Gerber
Journal:  Cerebellum       Date:  2012-09       Impact factor: 3.847

3.  Pathogenic polyglutamine proteins cause dendrite defects associated with specific actin cytoskeletal alterations in Drosophila.

Authors:  Sung Bae Lee; Joshua A Bagley; Hye Young Lee; Lily Yeh Jan; Yuh-Nung Jan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

Review 4.  Genetic targeting of cerebellar Purkinje cells: history, current status and novel strategies.

Authors:  Jaroslaw J Barski; Matthias Lauth; Michael Meyer
Journal:  Cerebellum       Date:  2002-04       Impact factor: 3.847

5.  In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice.

Authors:  Gülin Oz; Manda L Vollmers; Christopher D Nelson; Ryan Shanley; Lynn E Eberly; Harry T Orr; H Brent Clark
Journal:  Exp Neurol       Date:  2011-09-22       Impact factor: 5.330

6.  Early autophagic response in a novel knock-in model of Huntington disease.

Authors:  Mary Y Heng; Duy K Duong; Roger L Albin; Sara J Tallaksen-Greene; Jesse M Hunter; Mathieu J Lesort; Alex Osmand; Henry L Paulson; Peter J Detloff
Journal:  Hum Mol Genet       Date:  2010-07-08       Impact factor: 6.150

7.  SCA1-like disease in mice expressing wild-type ataxin-1 with a serine to aspartic acid replacement at residue 776.

Authors:  Lisa Duvick; Justin Barnes; Blake Ebner; Smita Agrawal; Michael Andresen; Janghoo Lim; Glenn J Giesler; Huda Y Zoghbi; Harry T Orr
Journal:  Neuron       Date:  2010-09-23       Impact factor: 17.173

8.  Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia.

Authors:  Dong-Hui Chen; Zoran Brkanac; Christophe L M J Verlinde; Xiao-Jian Tan; Laura Bylenok; David Nochlin; Mark Matsushita; Hillary Lipe; John Wolff; Magali Fernandez; P J Cimino; Thomas D Bird; Wendy H Raskind
Journal:  Am J Hum Genet       Date:  2003-03-17       Impact factor: 11.025

9.  Generation of human-induced pluripotent stem cells to model spinocerebellar ataxia type 2 in vitro.

Authors:  Guangbin Xia; Katherine Santostefano; Takashi Hamazaki; Jilin Liu; S H Subramony; Naohiro Terada; Tetsuo Ashizawa
Journal:  J Mol Neurosci       Date:  2012-12-09       Impact factor: 3.444

10.  RNAi or overexpression: alternative therapies for Spinocerebellar Ataxia Type 1.

Authors:  Megan S Keiser; James C Geoghegan; Ryan L Boudreau; Kim A Lennox; Beverly L Davidson
Journal:  Neurobiol Dis       Date:  2013-04-10       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.